Role of sphingolipids in the host-pathogen interaction.
Fungi
Glucosylceramide
Inositol phosphorylceramide
Pathogenicity
Sphingolipids
Journal
Biochimica et biophysica acta. Molecular and cell biology of lipids
ISSN: 1879-2618
Titre abrégé: Biochim Biophys Acta Mol Cell Biol Lipids
Pays: Netherlands
ID NLM: 101731727
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
07
02
2023
revised:
21
06
2023
accepted:
05
07
2023
medline:
9
10
2023
pubmed:
7
9
2023
entrez:
6
9
2023
Statut:
ppublish
Résumé
Fungal pathogens have been under the spotlight as their expanding geographic range combined with their potential harm to vulnerable populations turns them into increasingly threats to public health. Therefore, it is ultimately important to unveil the mechanisms associated with their infection process for further new treatment discovery. With this purpose, sphingolipid-based research has gained attention over the last years as these molecules have key properties that can regulate fungal pathogenicity. Here we discuss some of these properties as well as their role in fungal diseases, focusing on the subgroup of glycosphingolipids, as they represent promising molecules for drug discovery and for the development of fungal vaccines.
Identifiants
pubmed: 37673393
pii: S1388-1981(23)00108-7
doi: 10.1016/j.bbalip.2023.159384
pii:
doi:
Substances chimiques
Sphingolipids
0
Glycosphingolipids
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
159384Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Dr. Maurizio Del Poeta, M.D., is a Co-Founder and Chief Scientific Officer (CSO) of MicroRid Technologies Inc. whose goal is to develop new anti-fungal agents of therapeutic use. All other authors declare no competing interests.